Investigation Overview
An investigation on behalf of investors in Osiris Therapeutics, Inc. (NASDAQ: OSIR) shares over potential violations of the federal securities laws by Osiris Therapeutics, Inc was announced. According to the investigation by a law firm in January 2007, Osiris Therapeutics, Inc received Fast Track designation from the U.S. Food and Drug Administration, expediting the development of a ...
You must register (for free) or login to view the entire investigation.